1.

[Article] James, Philip D and Nash, Michael and Comiskey, Catherine and Prakashini Banka Cullen, Sonam (2026) Demographic and route to treatment differences between people using different substances in the Republic of Ireland: a comparative analysis using data from an EU wide treatment demand protocol. Journal of Drug Issues, Early online. https://doi.org/10.1177/00220426261419782

2.

[Article] Ledlie, Shaleesa and Garg, Ria and Leece, Pamela and Kolla, Gillian and Hyshka, Elaine and Tadrous, Mina and Gomes, Tara (2026) Trends in fentanyl-containing drug samples seized by law enforcement agencies across Canada. Addiction, Early online. https://doi.org/10.1111/add.70314

3.

[Article] Gworek, Hanne and Lombaerts, Tessa and Vanelderen, Pascal and Hubloue, Ives and Ordies, Sofie and Jan Van Asbroeck, Pieter (2026) Evaluating the impact of an on-site drug testing facility providing real-time drug alerts upon first-aid presentations at a Belgian festival. Drugs: Education Prevention and Policy, Early online. https://doi.org/10.1080/09687637.2026.2613864

4.

[News] RTE News. [RTE News] Rise in young people with ketamine-related bladder issues. (12 Jan 2026)

5.

[FactSheet] HRB National Drugs Library. (2026) Factsheet: New psychoactive substances (NPS) - the Irish situation 2026. Dublin: HRB National Drugs Library.

6.

[FactSheet] HRB National Drugs Library. (2026) Factsheet: Opioids - the Irish situation 2026. Dublin: HRB National Drugs Library.

7.

[FactSheet] HRB National Drugs Library. (2026) Factsheet: Sedatives and tranquilisers - the Irish situation 2026. Dublin: HRB National Drugs Library.

8.

[Article] Bastien, Gabriel and Abboud, Anita and McAnulty, Christina and Mahroug, Amani and Le Foll, Bernard and Socias, M Eugenia and Juteau, Louis-Christophe and Dubreucq, Simon and Jutras-Aswad, Didier (2026) Concordance between urine drug screening and self-reported use in the context of a pragmatic randomized-controlled trial in people with prescription-type opioid use disorder: Concordance entre le dépistage de drogues dans l'urine et l'usage autodéclaré dans le contexte d'un essai pragmatique contrôlé à répartition aléatoire chez des personnes présentant un trouble lié à l'usage d'opioïdes vendus sur ordonnance. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie, 71, (1), pp. 41-52. https://doi.org/10.1177/07067437251367180

9.

[Report] Public Health Scotland. (2026) Rapid Action Drug Alerts and Response (RADAR) quarterly reports 2026. Edinburgh: Public Health Scotland.

10.

[Article] Rock, Kirsten L and Treble, Ric and Copeland, Caroline S (2026) Legislating novel psychoactive substances: lessons from 15 years of UK mortality data (2007-2022). Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1708335

11.

[Article] Brennan, Margaret and Mongan, Deirdre and Doyle, Anne and Millar, Seán and Cavallaro, Massimo and Zgaga, Lina and Smyth, Bobby P and Nixon, Elizabeth and Ivers, Jo-Hanna and Galvin, Brian and Walsh, Cathal and McCrory, Cathal and McCarthy, Noel D (2026) Polysubstance use in early adulthood and associated factors in the Republic of Ireland: an analysis of a nationally representative cohort. Addiction, 121, (1), pp. 150-162. https://doi.org/10.1111/add.70182

12.

[Report] Medicines and Healthcare products Regulatory Agency. (2026) Drug safety update (DSU). Improving information supplied with gabapentinoids (pregabalin/gabapentin), benzodiazepines and z-drugs. London: Medicines and Healthcare products Regulatory Agency.

13.

[Article] Nielsen, Suzanne and Silva, João Pedro and Jones, Jermaine D and Krotulski, Alex and Poovendran, Dilkushi and Muzangizi, Deusdedit and Forte, Gilles and White, Jason and Comer, Sandra D (2026) Behavioural effects and naloxone effectiveness with new synthetic opioids. Drug and Alcohol Review, 45, (1). https://doi.org/10.1111/dar.70040

14.

[Article] Paredes Naveda, Alisson M and Oliva, Henrique Nunes Pereira and Ghadimi, Delaram J and Angarita, Gustavo A (2026) Actigraphy-based sleep outcomes in substance use disorders: a protocol for a systematic review and meta-analysis. PLoS ONE, 21, (1). https://doi.org/10.1371/journal.pone.0340595

15.

[Article] Roberts, Emmert and Hillyard, Miriam and Copeland, Caroline (2026) Characteristics of drug-related deaths among individuals identified as LGBTQ+ in the United Kingdom, 1997-2024. Addiction, 121, (1), pp. 208-214. https://doi.org/10.1111/add.70198

16.

[Article] Siefried, Krista J and Smith, Janette L and Harvey, Christine A and Nedanoski, Anthony and Brown, Jared A and Cullinan, Una and Ezard, Nadine and Jiranantakan, Thanjira and Roberts, Darren M and Brett, Jonathan (2026) Emergency department presentations, hospitalisations and police seizure data related to gamma-hydroxybutyrate (GHB) in New South Wales, Australia, from 2015 to 2024. Addiction, 121, (2), pp. 305-315. https://doi.org/10.1111/add.70202

17.

[Article] Sommer, Michaela J and Grafinger, Katharina Elisabeth and Hermanns-Clausen, Maren and Auwärter, Volker (2025) Development of a novel risk score reflecting the relative harm potential of synthetic cannabinoids based on prevalence estimates, well-documented intoxication cases and basic pharmacological data. Addiction, Early online. https://doi.org/10.1111/add.70268

18.

[Report] Forensic Science Ireland. (2025) Forensic Science Ireland annual report 2024. Dublin: Forensic Science Ireland.

19.

[Report] An Garda Siochana. (2025) An Garda Síochána annual report 2024. Dublin: An Garda Siochana.

20.

[Report] Medical Bureau of Road Safety. (2025) Medical Bureau of Road Safety annual report 2024. Dublin: Medical Bureau of Road Safety.

21.

[Article] Poulter, Hannah Louise and Silva, Peter Da and Moore, Helen J and Kesten, Joanna and MacKinnon, Mandy and Taylor, Gillian (2025) Peer research with populations of people who use street tablets in areas over-represented by drug-related harms in the UK: a case study. Harm Reduction Journal, Early online. https://doi.org/10.1186/s12954-025-01273-1

22.

[Article] Shiwach, Rajinder and Le Foll, Bernard and Alho, Hannu and Dunn, Kelly E and Strafford, Stephanie and Zhao, Yue and Dobbins, Robert L (2025) Comparison of extended-release buprenorphine doses for treating high-risk opioid use: a randomized clinical trial. JAMA Network Open, 8, (12). 10.1001/jamanetworkopen.2025.48043

23.

[Report] Kelleher, Cathy and Riordan, Fiona and Gopalakrishnan, Arya (2025) Drug poisoning deaths in Ireland in 2022: data from the National Drug-Related Deaths Index (NDRDI). Dublin: Health Research Board.

24.

[Report] Advisory Council on the Misuse of Drugs. (2025) Advisory Council on the Misuse of Drugs annual report (January 2023 to December 2025 consolidated). London: Advisory Council on the Misuse of Drugs.

25.

[Report] European Union Drugs Agency. (2025) Collection of drug-related hospital emergency data in Western Balkans and Southern Neighbourhood countries using Euro-DEN Plus methodology. Technical report. Luxembourg: Publications Office of the European Union.

26.

[Webpage] European Union Drugs Agency. (2025) European Drug Emergencies Network (Euro-DEN Plus): data and analysis. URL: https://www.euda.europa.eu/publications/data-facts...

27.

[Article] Frinculescu, Anca and Köring, Alexander and Shine, Trevor and Ramsey, John and Frascione, Nunzianda and Abbate, Vincenzo (2025) Diazepam quantification in street tablets using benchtop 1H qNMR spectroscopy: method validation and its application. Quantitative NMR Journal, 1. https://doi.org/10.64225/953ws951

28.

[Report] United Kingdom. Office for Health Improvement & Disparities. (2025) Substance misuse treatment statistics 2024 to 2025: report [adult and children]. London: Office for Health Improvement & Disparities.

29.

[News] [thejournal.ie] , Luke, Chris The current approach to drink spiking is not working - here's how we can tackle it. (24 Nov 2025)

30.

[Article] Wilkinson, Emma (2025) The rise of nitazenes: what pharmacists need to know. The Pharmacist,

31.

[News] [thejournal.ie] , Luke, Chris Medics should consider rethinking their attitude to drink spiking cases. (16 Nov 2025)

32.

[Audio] Fox, Laura and Killeen, Nicki (2025) Ketamine. Dublin: RTE.

33.

[News] [Irish Times] , Lally, Conor Drug-driving surging due to ‘really concerning’ rates of cocaine use. (12 Nov 2025)

34.

[Article] Alrahmani, Abdullah and Azeez, Mabast and Baker, Sahar and Kurdi, Amanj (2025) Impact of gabapentinoids' reclassification policy and COVID-19 on gabapentinoids' utilization pattern and their associated mortality in Scotland and Northern Ireland: a segmental regression analysis. Expert Review of Clinical Pharmacology, 18, (11), pp. 837-846. https://doi.org/10.1080/17512433.2025.2587174

35.

[Article] Chen, Shuoqi and Mais, David and Copeland, Caroline S (2025) Comparison of Office for National Statistics (ONS) and National Programme on Substance Use Mortality (NPSUM) data suggests that opioid-related deaths in England & Wales have been systematically underestimated. International Journal of Drug Policy, 145. https://doi.org/10.1016/j.drugpo.2025.104976

36.

[Report] House of Commons Justice Committee. (2025) Tackling the drugs crisis in our prisons. London: House of Commons.

37.

[Report] Ireland. Office of the Inspector of Prisons. (2025) Office of the Inspector of Prisons annual report 2024. Dublin: Office of the Inspector of Prisons.

38.

[Report] Morris, Sarah and Hill, Suzanne and McManus, Sally and Brugha, ​​Traolach (2025) Adult psychiatric morbidity survey: survey of mental health and wellbeing, England, 2023/4. London: NHS England.

39.

[Report] United Nations Office on Drugs and Crime. (2025) Afghanistan opium survey 2025. Vienna: UNODC.

40.

[Report] Man, Nicola and Chrzanowska, Agata and Sutherland, Rachel and Sadaphale, Vandit and Barratt, Monica J and Bruno, Raimondo and Peacock, Amy (2025) Availability of nitazenes for purchase in Australia and internationally via cryptomarkets, September 2021 - August 2025. UNSW Sydney: National Drug and Alcohol Research Centre.